retatrutide diabetes type 2 Retatrutide—A Game Changer in Obesity Pharmacotherapy Comparative Efficacy and Safety of

A clinician will also consider: Your BMI and health conditions Your current medication Your previous experience with weight loss treatment Your risk of side effects How easily you can follow the dosing instructions Whether the treatment is licensed and available Your long-term health goals For some patients, Wegovy tablets may be more appropriate

Their basal metabolic rate decreases

48 In patients with MASH-related cirrhosis and severe portal hypertension, emricasan could not improve either HVPG or clinical outcomes (NCT02960204)

Postgrad Med J 96(1133):156161 Singh K, Aulakh SK, Nijjar GS, Singh S, Sandhu APS, Luthra S, et al (2024) Rebalancing the gut: glucagon-like peptide-1 agonists as a strategy for obesity and metabolic health